Senseonics (SENS) Competitors $0.50 0.00 (-0.62%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$0.50 +0.00 (+0.02%) As of 07/11/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SENS vs. TRNS, EYPT, ALNT, LAB, CTKB, AEHR, QSI, QTRX, MASS, and FEIMShould you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Quantum-Si (QSI), Quanterix (QTRX), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry. Senseonics vs. Its Competitors Transcat Eyepoint Pharmaceuticals Allient Standard BioTools Cytek Biosciences Aehr Test Systems Quantum-Si Quanterix 908 Devices Frequency Electronics Senseonics (NYSE:SENS) and Transcat (NASDAQ:TRNS) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, profitability, institutional ownership, analyst recommendations, earnings and valuation. Which has more risk and volatility, SENS or TRNS? Senseonics has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Transcat has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Which has higher earnings & valuation, SENS or TRNS? Transcat has higher revenue and earnings than Senseonics. Senseonics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSenseonics$23.68M13.73-$60.39M-$0.11-4.52Transcat$278.42M2.90$14.52M$1.5655.51 Does the media prefer SENS or TRNS? In the previous week, Transcat had 1 more articles in the media than Senseonics. MarketBeat recorded 5 mentions for Transcat and 4 mentions for Senseonics. Senseonics' average media sentiment score of 1.03 beat Transcat's score of 0.67 indicating that Senseonics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Senseonics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Transcat 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is SENS or TRNS more profitable? Transcat has a net margin of 5.21% compared to Senseonics' net margin of -362.30%. Transcat's return on equity of 6.47% beat Senseonics' return on equity.Company Net Margins Return on Equity Return on Assets Senseonics-362.30% -842.25% -67.99% Transcat 5.21%6.47%5.02% Do insiders & institutionals hold more shares of SENS or TRNS? 12.4% of Senseonics shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 4.3% of Senseonics shares are owned by company insiders. Comparatively, 2.3% of Transcat shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts recommend SENS or TRNS? Senseonics currently has a consensus target price of $1.70, suggesting a potential upside of 242.12%. Transcat has a consensus target price of $112.20, suggesting a potential upside of 29.58%. Given Senseonics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Senseonics is more favorable than Transcat.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Senseonics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Transcat 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 SummaryTranscat beats Senseonics on 10 of the 17 factors compared between the two stocks. Get Senseonics News Delivered to You Automatically Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SENS vs. The Competition Export to ExcelMetricSenseonicsProcess control instruments IndustryMedical SectorNYSE ExchangeMarket Cap$325.08M$19.73B$5.61B$20.79BDividend YieldN/A0.58%5.24%3.71%P/E Ratio-3.8219.0927.9627.89Price / Sales13.737.29430.8942.50Price / CashN/A22.2637.4622.63Price / Book7.105.108.044.57Net Income-$60.39M$495.21M$3.18B$988.81M7 Day Performance-0.42%-2.43%3.68%0.20%1 Month Performance-4.44%-4.37%4.10%3.93%1 Year Performance5.66%1.85%29.59%10.27% Senseonics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SENSSenseonics2.0967 of 5 stars$0.50-0.6%$1.70+242.1%+5.9%$325.08M$23.68M-3.8290News CoveragePositive NewsAnalyst ForecastAnalyst RevisionTRNSTranscat2.9503 of 5 stars$85.96+1.3%$114.00+32.6%-30.6%$801.15M$278.42M55.101,245News CoverageAnalyst ForecastEYPTEyepoint Pharmaceuticals1.7558 of 5 stars$9.41-2.4%$25.67+172.8%+4.5%$647.50M$43.27M-3.90120ALNTAllient2.3043 of 5 stars$36.31+1.1%$31.00-14.6%+46.6%$614.73M$529.97M61.542,525Positive NewsLABStandard BioTools3.5842 of 5 stars$1.20+0.8%$2.50+108.3%-32.7%$455.78M$174.43M-3.43620Positive NewsCTKBCytek Biosciences3.1065 of 5 stars$3.40-4.2%$5.60+64.7%-44.3%$430.64M$200.45M-37.77500AEHRAehr Test Systems3.4806 of 5 stars$12.93+3.3%$25.00+93.3%-6.6%$384.93M$66.22M16.5890News CoverageEarnings ReportAnalyst RevisionQSIQuantum-Si1.9701 of 5 stars$1.96+0.5%$3.48+77.3%+60.2%$359.66M$3.06M-2.88150QTRXQuanterix2.4058 of 5 stars$6.65flat$15.60+134.6%-58.2%$332.19M$133.92M-5.12460News CoverageMASS908 Devices1.3159 of 5 stars$7.13+5.9%$5.33-25.2%+30.0%$255.68M$59.63M-13.2060FEIMFrequency Electronics1.5968 of 5 stars$22.71-2.4%N/A+120.7%$219.83M$55.27M9.42200Trending NewsEarnings ReportGap DownHigh Trading Volume Related Companies and Tools Related Companies TRNS Alternatives EYPT Alternatives ALNT Alternatives LAB Alternatives CTKB Alternatives AEHR Alternatives QSI Alternatives QTRX Alternatives MASS Alternatives FEIM Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SENS) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s whole-government AI plans leakedThe New Elon Musk is officially stepping back from his day-to-day duties with DOGE. At least, that's the s...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senseonics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SENS Stock Alerts